Volume 64 Received 4 August 2008 | ||||||||||
| ||||||||||
2N,N')nickel(II)]-
-oxalato-
4O1,O2:O1',O2']aInstitute of Immunology, Key Laboratory of Natural Drugs and Immunological Engineering of Henan Province, College of Medicine, Henan University, Kaifeng 475003, People's Republic of China,bFirst Affiliated Hospital, Henan University, Kaifeng 475003, People's Republic of China, and cCollege of Chemistry and Chemical Engineering, Henan University, Kaifeng 475003, People's Republic of China
Correspondence e-mail: mayf_hd@126.com
The title compound, [Ni(C2O4)(C10H8N2)]n, is isostructural with its MnII, FeII, CuII and ZnII analogues. Each NiII atom is chelated by two oxalate ligands and one 2,2'-bipyridine, forming a slightly distorted octahedral geometry. Oxlate acts as a bridge to link neighbouring pairs of NiII cations, forming a one-dimensional wave-like chain. The crystal showed partial inversion twinning.
For related literature, see: Hong & Do (1997
); Eddaoudi et al. (2001
); Liang et al. (2004
); Shi et al. (2005
). For the isostructural MnII, FeII, CuII and ZnII complexes, see: Li et al. (2006
); Deguenon et al. (1990
); Fun et al. (1999
); Luo et al. (2001
); Yu et al. (2006
); Lin et al. (2006
).
|
|
Data collection: APEX2 (Bruker, 2004
); cell refinement: SAINT-Plus (Bruker, 2001
); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: SHELXTL (Sheldrick, 2008
); software used to prepare material for publication: SHELXTL.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CF2213 ).
The authors are grateful for financial support from the Scientific Research Foundation of Outstanding Talented Persons of Henan Province (grant No. 74200510014).
Bruker (2001). SADABS and SAINT-Plus. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2004). APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.
Deguenon, D., Bernardinelli, G., Tuchagues, J. P. & Castan, P. (1990). Inorg. Chem. 29, 3031-3039.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Eddaoudi, M., Kim, J., Wachter, J. B., Chae, H. K., Keeffe, M. O. & Yaghi, O. M. (2001). J. Am. Chem. Soc. 123, 4368-4369.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Flack, H. D. (1983). Acta Cryst. A39, 876-881.
![[details]](../../../../../../a/graphics/details.gif)
Fun, H.-K., Shanmuga Sundara Raj, S., Fang, X., Zheng, L.-M. & Xin, X.-Q. (1999). Acta Cryst. C55, 903-905.
![[details]](../../../../../../c/graphics/details.gif)
Hong, C. S. & Do, Y. (1997). Inorg. Chem. 36, 5684-5685.
![[ISI]](../../../../../../logos/isiborder.gif)
Li, L. L., Lin, K. J., Ho, C. J., Sun, C. P. & Yang, H. D. (2006). Chem. Commun. pp. 1286-1287. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Liang, M., Sun, Y. Q., Liao, D. Z., Jiang, Z. H., Yan, S. P. & Cheng, P. (2004). J. Coord. Chem. 57, 275-280.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Lin, X.-R., Ye, B.-Z., Liu, J.-S., Wei, C.-X. & Chen, J.-X. (2006). Acta Cryst. E62, m2130-m2132.
![[details]](../../../../../../e/graphics/details.gif)
Luo, J.-H., Hong, M.-C., Liang, Y.-C. & Cao, R. (2001). Acta Cryst. E57, m361-m362.
![[details]](../../../../../../e/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Shi, J. M., Yin, H. L. & Wu, C. J. (2005). J. Coord. Chem. 58, 915-920.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Yu, J. H., Hou, Q., Bi, M. H., Lu, Z. L., Zhang, X., Qu, X. J., Lu, J. & Xu, J. Q. (2006). J. Mol. Struct. 800, 69-75.
![[ChemPort]](../../../../../../logos/chemportborder.gif)